🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lifecore Biomedical, Inc.

LFCR Healthcare
$6.4 +$0.03 (0.47%)
Market Cap: $242.26 M
Gurus Holding
4
Popularity Rank
#2376
% of Shares Held
0.78%
Net Activity (Q2 2026)
+$780,499.54

Guru Ownership Trend

Guru Analysis for Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical, Inc. (LFCR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.9 M.

Top institutional holders include Renaissance Technologies (RenTech) and Mario Gabelli.

Institutional sentiment is currently Bullish. This is evidenced by a $780,499.54 net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 250.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$901,399.54
Total Buy Value
New Buys 1
Additions 2
-$120,900
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Lifecore Biomedical, Inc. (LFCR)

Major holders include Renaissance Technologies (RenTech) ($550,510), Mario Gabelli ($439,950), Cliff Asness ($291,969). According to the latest reported data, 4 tracked investment managers collectively hold approximately 296,792 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $780,499.54, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited LFCR. The total reported sell value was $120,900.

Yes, 1 managers opened new positions in LFCR, and 2 increased their existing holdings. The total reported buy value was $901,399.54.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 104,859 $550,510 Q2 2026
0.00% 83,800 $439,950 Q2 2026
0.00% Add 250.4% 55,613 $291,969 Q2 2026
0.00% Add 106.6% 52,520 $275,730 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form